# FDA recall D-0003-2026

> **RC Outsourcing, LLC** · Class II · drug recall initiated 2025-09-22.

## Product

Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.

## Reason for recall

Lack of assurance of sterility.

## Distribution

Nationwide in the US

## Key facts

- **Recall number:** D-0003-2026
- **Recalling firm:** RC Outsourcing, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2025-09-22
- **Report date:** 2025-10-15
- **Termination date:** 2026-01-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lowellville, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0003-2026

## Citation

> AI Analytics. FDA recall D-0003-2026. Retrieved 2026-08-17 from https://api.ai-analytics.org/recall/D-0003-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*